Health Canada drug identification number

DIN 02456532 — BEPREVE 1.5 %

BEPREVE is a solution of Bepotastine besilate marketed by BAUSCH & LOMB INC. The full Bepotastine besilate monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02456532
Brand name
BEPREVE
Active ingredient
Bepotastine besilate
Strength
1.5 %
Dosage form
SOLUTION
Route
OPHTHALMIC
Manufacturer
BAUSCH & LOMB INC
Health Canada status
MARKETED
Drug class
Selective histamine H1-receptor antagonist (ophthalmic antihistamine)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.